These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19886845)

  • 1. Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case series.
    Grigoleit GU; Kapp M; Tan SM; Unzicker C; Einsele H; Mielke S; Topp MS; Stuhler G
    Leuk Lymphoma; 2009 Dec; 50(12):2071-4. PubMed ID: 19886845
    [No Abstract]   [Full Text] [Related]  

  • 2. Last exit clofarabine?
    Faderl S
    Leuk Lymphoma; 2009 Dec; 50(12):1907-8. PubMed ID: 20001243
    [No Abstract]   [Full Text] [Related]  

  • 3. A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia.
    Hijiya N; Gaynon P; Barry E; Silverman L; Thomson B; Chu R; Cooper T; Kadota R; Rytting M; Steinherz P; Shen V; Jeha S; Abichandani R; Carroll WL
    Leukemia; 2009 Dec; 23(12):2259-64. PubMed ID: 19741725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients.
    Miano M; Pistorio A; Putti MC; Dufour C; Messina C; Barisone E; Ziino O; Parasole R; Luciani M; Lo Nigro L; De Rossi G; Varotto S; Bertorello N; Petruzziello F; Calvillo M; Micalizzi C
    Leuk Lymphoma; 2012 Sep; 53(9):1693-8. PubMed ID: 22303898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia.
    Papayannidis C; Derenzini E; Iacobucci I; Curti A; Paolini S; Cilloni D; Baccarani M; Martinelli G
    Am J Hematol; 2009 Dec; 84(12):849-50. PubMed ID: 19844989
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of relapsed or refractory acute myeloid leukemia by clofarabine in preparation for allogeneic stem cell transplant.
    Loeffler C; Kapp M; Grigoleit GU; Mielke S; Loeffler J; Heuschmann PU; Malzahn U; Hupp E; Einsele H; Stuhler G
    Leuk Lymphoma; 2015; 56(12):3365-9. PubMed ID: 26014275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
    McGregor BA; Brown AW; Osswald MB; Savona MR
    Am J Hematol; 2009 Apr; 84(4):228-30. PubMed ID: 19260120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.
    Huguet F; Leguay T; Raffoux E; Rousselot P; Vey N; Pigneux A; Ifrah N; Dombret H
    Leuk Lymphoma; 2015 Apr; 56(4):847-57. PubMed ID: 24996442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee).
    Nelken B; Cave H; Leverger G; Galambrun C; Plat G; Schmitt C; Thomas C; Vérité C; Brethon B; Gandemer V; Bertrand Y; Baruchel A; Rohrlich P
    Pediatr Blood Cancer; 2016 Feb; 63(2):270-5. PubMed ID: 26376115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience.
    Barba P; Sampol A; Calbacho M; Gonzalez J; Serrano J; Martínez-Sánchez P; Fernández P; García-Boyero R; Bueno J; Ribera JM
    Am J Hematol; 2012 Jun; 87(6):631-4. PubMed ID: 22431002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia.
    Steinherz PG; Shukla N; Kobos R; Steinherz L
    Pediatr Blood Cancer; 2010 May; 54(5):687-93. PubMed ID: 20205253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine+cytarabine.
    Knoebel RW; McQuary A; Becker P; Hendrie P; Petersdorf S; Appelbaum FR; Estey E
    Leuk Res; 2011 Sep; 35(9):e164-6. PubMed ID: 21684006
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clofarabine-based combination chemotherapy for relapse and refractory childhood acute lymphoblastic leukemia].
    Arakawa Y; Koh K; Aoki T; Kubota Y; Oyama R; Mori M; Hayashi M; Hanada R
    Rinsho Ketsueki; 2014 Nov; 55(11):2316-9. PubMed ID: 25501414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia.
    Farag SS; Wood LL; Schwartz JE; Srivastava S; Nelson RP; Robertson MJ; Abonour R; Secrest A; Cox E; Baute J; Sullivan C; Kane K; Jones DR
    Leukemia; 2011 Apr; 25(4):599-605. PubMed ID: 21252987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia.
    Advani AS; McDonough S; Coutre S; Wood B; Radich J; Mims M; O'Donnell M; Elkins S; Becker M; Othus M; Appelbaum FR
    Br J Haematol; 2014 May; 165(4):504-9. PubMed ID: 24579885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias.
    Zeidan AM; Ricklis RM; Carraway HE; Yun HD; Greer JM; Smith BD; Levis MJ; McDevitt MA; Pratz KW; Showel MM; Gladstone DE; Gore SD; Karp JE
    Br J Haematol; 2012 Jul; 158(2):198-207. PubMed ID: 22594769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.
    Karp JE; Ricklis RM; Balakrishnan K; Briel J; Greer J; Gore SD; Smith BD; McDevitt MA; Carraway H; Levis MJ; Gandhi V
    Blood; 2007 Sep; 110(6):1762-9. PubMed ID: 17562873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I and extension study of clofarabine plus cyclophosphamide in patients with relapsed/refractory acute lymphoblastic leukemia.
    Faderl S; Balakrishnan K; Thomas DA; Ravandi F; Borthakur G; Burger J; Ferrajoli A; Cortes J; O'Brien S; Kadia T; Feliu J; Plunkett W; Gandhi V; Kantarjian HM
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):231-8. PubMed ID: 24440659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia.
    Inaba H; Rubnitz JE; Coustan-Smith E; Li L; Furmanski BD; Mascara GP; Heym KM; Christensen R; Onciu M; Shurtleff SA; Pounds SB; Pui CH; Ribeiro RC; Campana D; Baker SD
    J Clin Oncol; 2011 Aug; 29(24):3293-300. PubMed ID: 21768474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clofarabine/cyclophosphamide for debulking before stem cell transplantation.
    Rabitsch W; Böhm A; Bojic M; Schellongowski P; Wöhrer S; Sliwa T; Keil F; Worel N; Greinix H; Hauswirth A; Kalhs P; Jaeger U; Valent P; Sperr WR
    Eur J Clin Invest; 2014 Aug; 44(8):775-83. PubMed ID: 24942362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.